Cancer Council Australia

Larger Text Smaller Text Print

Prostate cancer

Prostate cancer is the second most common cancer among Australians after non-melanoma skin cancer1, with more than 17,000 new cases projected to be diagnosed in 2018. And it is the second most common cause of cancer death among Australian men, after lung cancer.

Tests aimed at helping diagnose prostate cancer are available. However, there is no national screening program in place, with current evidence showing that the PSA test is not suitable for population screening as the harms outweigh the benefits. Whether or not to be tested for prostate cancer is a matter of individual choice.

The prostate cancer chapter of our National Cancer Prevention Policy contains evidence-based information on prostate cancer screening, and outlines Cancer Council Australia's policy priorities for improving outcomes from early detection of prostate cancer.

Cancer Council Australia and the Australian Health Ministers' Advisory Council - key messages on prostate cancer screening

Cancer Council Australia and the intergovernmental Australian Health Ministers? Advisory Council have developed a joint statement summarising key messages about screening for prostate cancer, including an interpretation of the two large international trials of PSA as a screening tool.

The statement has been endorsed by the Royal Australian College of General Practitioners, the professional organisation that focuses on the safety and quality of general practice, and Andrology Australia, the nation's centre of excellence in male reproductive health.

Joint key messages

1) Non-melanoma skin cancer is the most commonly diagnosed cancer according to general practice and hospitals data, however there is no reporting of cases to cancer registries.

This page was last updated on: Wednesday, April 18, 2018

Web design Code and Visual